22 - 24 May in Saint Petersburg hosted the 18th International Russian
Pharmaceutical Forum Adam Smith Institute. It is probably the biggest
event pharmaceutical industry in Russia, in which recognized experts,
the top management of the world's leading companies take part every
year. Analysis of current business climate, legal aspects of activities,
the key trends and development prospects of pharmaceutical industry of
Russia are not the whole range of issues raised at the conference. There
have been conducted just more than 15 sessions which allowed
participants to get a comprehensive picture of the state of the industry
This year, the forum was attended by more than 90 speakers. Among them
were the leaders of both Russian and foreign pharmaceutical companies,
distributors, retail chains and government officials, legal consultants.
Nikita Minayev, the Director of Business Development of Geropharm was
invited to the forum as one of the industry experts; he spoke at the
session on the innovative development of the industry. Also the event
was attended by top managers of the Russian and international companies,
such as STADA Group, AstraZeneca, Novartis Consumer Health, Akrikhin.
During the session, the speakers reviewed the main sources of
innovation development, among which was named R&D, mergers and
acquisitions and strategic alliances. The speakers shared their
international experience of successful partnership deals, highlighted
key trends in the local market and also touched on the basic legal
Development of R&D in Russia was a separate topic of the
discussion. Mr. Minayev, in his speech stated that today the country has
created favourable conditions for the nucleation of innovations. There
are investments and support from the state for this purpose that gives
rise to creation of modern scientific research centres in Russia.
Geropharm’s representative shared its experience in creation of modern
R&D centre of a world-class, which was opened in December 2011 in a
special economic zone Neudorf. Today innovative medicines are developing
in laboratories of the centre; such medicines will eventually be
produced at Geropharm industrial sites.
In addition, the presenter added that Geropharm open to international
cooperation and various forms of cooperation with the Russian and
foreign companies. A number of projects aimed at development of
innovative medicinal preparations are already being shared with foreign
colleagues from the U.S., Japan, Australia and Italy.
The recent Russian Pharmaceutical Forum, of course, became one of the most interesting events in its field. As noted by the participants, the event provides a unique opportunity to get familiarized with different points of view about future paths of development of the Russian pharmacy and find solutions to existing problems by means of cooperation.